• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>ViroPharma

ViroPharma

  1. MetaStat Appoints Martin J. Driscoll to Board of Directors

    MetaStat Appoints Martin J. Driscoll to Board of Directors

  2. UPDATE: Dyax shares jump 55% on 'best-in-class' potential for new drug

    UPDATE: Dyax shares jump 55% on 'best-in-class' potential for new drug

  3. Dyax shares jump 40% on 'best-in-class' potential for new drug

    Dyax shares jump 40% on 'best-in-class' potential for new drug

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.